Randomized, comparative trial of DOX-SL (stealth liposomal doxorubicin hydrochloride) [doxorubicin liposomal] versus adriamycin [doxorubicin], bleomycin, and vincristine (ABV) in the treatment of severe AIDS-related Kaposi's sarcoma

Trial Profile

Randomized, comparative trial of DOX-SL (stealth liposomal doxorubicin hydrochloride) [doxorubicin liposomal] versus adriamycin [doxorubicin], bleomycin, and vincristine (ABV) in the treatment of severe AIDS-related Kaposi's sarcoma

Active, no longer recruiting
Phase of Trial: Phase III

Latest Information Update: 11 Sep 2005

At a glance

  • Drugs Bleomycin; Doxorubicin; Doxorubicin liposomal; Vincristine
  • Indications Kaposi's sarcoma
  • Focus Therapeutic Use
  • Most Recent Events

    • 11 Sep 2005 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top